[Advancing breakthroughs in the diagnosis and treatment of osteonecrosis of the jaw, and exploring optimized precision treatment strategy].

Osteonecrosis of the jaw is increasingly common following cancer treatment or use of bone-targeting drugs; recent advances in understanding its causes, staging systems, and treatment approaches—including precision medicine and regenerative techniques—are improving clinical management of this challenging condition.

A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.